Melanoma is the sixth most frequent malignancy. It represents 1.7% of all cancer cases
worldwide. Many risk factors are associated with melanoma including ultraviolet radiation …

Cutaneous melanoma is the deadliest and most aggressive form of skin cancer owing to its
high capacity for metastasis. Over the past few decades, the management of this type of …

The detection of melanoma circulating biomarker in liquid biopsies is current under
evaluation for being potentially utilized for earlier cancer diagnosis and its metastasis …

Precision medicine has driven a major change in the treatment of many forms of cancer. The
discovery that each patient is different and each tumor mass has its own characteristics has …

Background Noninvasive molecular biomarkers are needed to improve the early, accurate
and precise diagnosis of invasive cutaneous melanoma. Objectives To independently …

Secreted extracellular vesicles (EVs) are lipid bilayer particles without functional nucleus
naturally released from cells which constitute an intercellular communication system. There …

The approval of immunotherapy for stage II-IV melanoma has underscored the need for
improved immune-based predictive and prognostic biomarkers. For resectable stage II-III …

Simple Summary Cutaneous melanoma, a fatal and aggressive tumor, has witnessed a
transformative shift in its clinical management over the past decade with the advent of anti …

Background and aims With the development of novel therapies for advanced malignant
melanoma (MM), biomarkers that can accurately reflect the progression of MM are needed …

Cancer radical surgery is the primary treatment for melanoma, but almost all malignant
melanoma patients get recurrence and metastasis after surgery and are eventually dead …